Last update 04 Jun 2025

Balcinrenone/Dapagliflozin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Balcinrenone/达格列净, Balcinrenone达格列净
Action
modulators, inhibitors
Mechanism
MR modulators(Mineralocorticoid receptor modulators), SGLT2 inhibitors(Sodium/glucose cotransporter 2 inhibitors)
Inactive Indication-
Originator Organization
Inactive Organization-
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC24H35ClO9
InChIKeyGOADIQFWSVMMRJ-UPGAGZFNSA-N
CAS Registry960404-48-2
View All Structures (2)

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Heart FailurePhase 3
United States
12 Apr 2024
Heart FailurePhase 3
Japan
12 Apr 2024
Heart FailurePhase 3
Argentina
12 Apr 2024
Heart FailurePhase 3
Australia
12 Apr 2024
Heart FailurePhase 3
Austria
12 Apr 2024
Heart FailurePhase 3
Brazil
12 Apr 2024
Heart FailurePhase 3
Bulgaria
12 Apr 2024
Heart FailurePhase 3
Canada
12 Apr 2024
Heart FailurePhase 3
Chile
12 Apr 2024
Heart FailurePhase 3
Colombia
12 Apr 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free